TERACT EO 1 (F:6O8) — Stock Price

€2.71 EUR
▼ -4.91% today

TERACT EO 1 (F:6O8) is currently trading at €2.71 EUR, down 4.91% today. Over the past 52 weeks, shares have ranged between €0.88 and €2.97. This page tracks TERACT EO 1's live share price on the F exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see 6O8 market cap.

TERACT EO 1 (6O8) Stock Price Chart — Daily History & Trading Volume

The chart below tracks TERACT EO 1's daily closing share price and trading volume on the F exchange over the past year, giving a clear view of recent price momentum and liquidity.

TERACT EO 1 Income Statement — Revenue, Profit & Earnings by Year

TERACT EO 1's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 202420232021
Total Revenue €894.80 Million €902.20 Million €867.10 Million
Cost of Revenue €489.70 Million €520.60 Million €464.90 Million
Gross Profit €405.10 Million €381.60 Million €402.20 Million
Research & Development
SG&A €34.50 Million €35.20 Million €65.40 Million
Total Operating Expenses €907.10 Million €996.90 Million €794.10 Million
Operating Income €-12.30 Million €-94.70 Million €73.00 Million
EBITDA
EBIT
Interest Expense €25.50 Million €17.00 Million €44.21 Million
Income Before Tax €-55.70 Million €-108.20 Million €35.30 Million
Income Tax Expense
Net Income €-68.90 Million €-106.60 Million €34.70 Million

TERACT EO 1 Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes TERACT EO 1's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 2024202320222021
Total Assets €1.17 Billion €1.22 Billion €957.80 Million €938.40 Million
Total Current Assets €428.40 Million €447.80 Million €414.00 Million €422.40 Million
Cash & Equivalents
Short-term Investments
Net Receivables €168.50 Million €155.80 Million €155.80 Million €158.50 Million
Inventory €158.20 Million €169.70 Million €165.00 Million €135.80 Million
Property, Plant & Equipment
Goodwill €262.90 Million €272.30 Million €112.30 Million €81.90 Million
Total Liabilities €898.10 Million €882.40 Million €701.40 Million €796.30 Million
Total Current Liabilities €463.00 Million €584.70 Million €420.20 Million €402.20 Million
Long-term Debt €210.00 Million €73.90 Million €71.80 Million €176.40 Million
Net Debt €269.50 Million €222.30 Million €136.50 Million €178.90 Million
Total Stockholder Equity €261.90 Million €329.70 Million €253.30 Million €139.00 Million
Retained Earnings €-68.90 Million €-106.60 Million €34.70 Million

TERACT EO 1 Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how TERACT EO 1 generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 202420232021
Operating Cash Flow €35.50 Million €72.60 Million €91.90 Million
Capital Expenditures €39.00 Million €29.00 Million €27.80 Million
Free Cash Flow €-3.50 Million €43.60 Million €64.10 Million
Investing Cash Flow
Financing Cash Flow
Dividends Paid
Stock-Based Compensation
Depreciation €86.80 Million €67.40 Million €57.00 Million
Change in Cash €3.90 Million €-3.50 Million €28.20 Million

TERACT EO 1 Earnings History — EPS Actual vs. Analyst Estimates

Track TERACT EO 1's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Dec 13, 2024